Followers | 5 |
Posts | 2631 |
Boards Moderated | 0 |
Alias Born | 08/25/2018 |
Wednesday, November 25, 2020 1:09:14 PM
As I mentioned before, it helps to do comparisons. There's another healthcare company, AVX*, that has ZERO revenues and is trading over $300 million. Can you believe it? And yes, you are correct, in order to sustain a ZERO REV company an incredible amount of dilution has to happen. Luckily, for DFCO, this is not the case because of the MASSIVE REVS it is generating, partly from its Dalrada Health line. Did I mention DFCO is trading at only a $7 mil market cap. What an opportunity!!!!
Recent DFCO News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 07:39:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:18:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:19:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:25:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 02:51:49 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/19/2023 07:57:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:06:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 12:01:32 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 11:53:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 09:23:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 06:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:15:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:13:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/13/2023 11:59:05 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM